CURIS INC Uncategorized Contracts & Agreements

47 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Material contractsManagement Contracts and Compensatory Plans
CURIS INC
Biotechnology
2024
Material contractsManagement Contracts and Compensatory Plans
CURIS INC
Biotechnology
DE
2023
Material contractsManagement Contracts and Compensatory Plans
CURIS INC
Biotechnology
DE
2022
Material contractsManagement Contracts and Compensatory Plans
CURIS INC
Biotechnology
DE
2021
Material contractsMiscellaneous
CURIS INC
Biotechnology
NY
2020
Material contractsManagement Contracts and Compensatory Plans
CURIS INC
Biotechnology
DE
2020
Consent and Payment Direction Letter Agreement, dated March 22, 2019, by and between Curis, Inc., Curis Royalty LLC and Genentech, Inc
CURIS INC
Biotechnology
DE
2019
Letter Agreement, entered into on August 1, 2018, by and between Curis, Inc. and David Tuck, M.D
CURIS INC
Biotechnology
MA
2018
Material contractsLeases
CURIS INC
Biotechnology
MA
2018
[Form of Online Cover Sheet]
CURIS INC
Biotechnology
2017
[Form of Online Cover Sheet]
CURIS INC
Biotechnology
2017
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
CURIS INC
Biotechnology
2016
CURIS, INC. 4 Maguire Road Lexington, MA 02421
CURIS INC
Biotechnology
MA
2016
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
CURIS INC
Biotechnology
CA
2015
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
CURIS INC
Biotechnology
NY
2015
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
CURIS INC
Biotechnology
2015
Effective March 17, 2014
CURIS INC
Biotechnology
2014
Effective December 31, 2013
CURIS INC
Biotechnology
2014
Confidential Materials omitted and filed separately with the Securities andExchange Commission. Double asterisks denote omissions.
CURIS INC
Biotechnology
NY
2013
CONSENT AND ACKNOWLEDGEMENT OF PAYMENT DIRECTION
CURIS INC
Biotechnology
2013
Effective December 31, 2012
CURIS INC
Biotechnology
2013
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
CURIS INC
Biotechnology
CA
2012
- 2 -
CURIS INC
Biotechnology
MA
2012
SECOND AMENDMENT TO OFFER LETTER
CURIS INC
Biotechnology
2011
THIRD AMENDMENT TO OFFER LETTER
CURIS INC
Biotechnology
2011
FOURTH AMENDMENT TO OFFER LETTER
CURIS INC
Biotechnology
2011
THIRD AMENDMENT TO OFFER LETTER
CURIS INC
Biotechnology
2011
AMENDMENT TO OFFER LETTER
CURIS INC
Biotechnology
DE
2010
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.
CURIS INC
Biotechnology
2009
[Curis Letterhead]
CURIS INC
Biotechnology
2008
[Curis Letterhead]
CURIS INC
Biotechnology
2008
[Curis Letterhead]
CURIS INC
Biotechnology
2008
[Curis Letterhead]
CURIS INC
Biotechnology
2008
AMENDMENT TO OFFER LETTER
CURIS INC
Biotechnology
DE
2008
/S/ DANIEL R. PASSERI
CURIS INC
Biotechnology
2007
AMENDMENT TO OFFER LETTER
CURIS INC
Biotechnology
DE
2006
AMENDMENT TO OFFER LETTER
CURIS INC
Biotechnology
DE
2006
AMENDMENT TO OFFER LETTER
CURIS INC
Biotechnology
DE
2006
CURIS, INC.
CURIS INC
Biotechnology
2004
CURIS, INC.
CURIS INC
Biotechnology
2004